Lim et al. [28] proposed a method for studying the association between inflammation, the kynurenine pathway (KP), and MS pathogenesis as they identified that serum KP metabolic signatures in patients can be used to distinguish clinical MS subtypes with high specificity and sensitivity. The gene discussed is NPPA; the disease is myeloid sarcoma.